Showing results (1981-1990 of 2,011) with videos related to
Sort By:
Pageof 202
Tropical Animal Health and Production|June 1, 2026
River transport of cattle in northern Brazil - a systematic reviewWelligton Conceição da Silva, Éder Bruno Rebelo da Silva, Italo Messias Ferreira de Souza, et al.Blood|July 28, 2021
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcomeFranziska Taube, Julia Annabell Georgi, Michael Kramer, et al.Nature Communications|August 14, 2023
An integrated organoid omics map extends modeling potential of kidney diseaseMoritz Lassé, Jamal El Saghir, Celine C Berthier, et al.Blood|June 5, 2020
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?Christoph Röllig, Michael Kramer, Christoph Schliemann, et al.BMC Genomics|January 8, 2010
The dynamic architecture of the metabolic switch in Streptomyces coelicolorKay Nieselt, Florian Battke, Alexander Herbig, et al.Nature|October 16, 2015
Biodiversity increases the resistance of ecosystem productivity to climate extremesForest Isbell, Dylan Craven, John Connolly, et al.Plos Computational Biology|February 8, 2024
Multiscale networks in multiple sclerosisKeith E Kennedy, Nicole Kerlero de Rosbo, Antonio Uccelli, et al.Journal of Medicinal Chemistry|April 9, 2021
Targeting Chikungunya Virus Replication by Benzoannulene InhibitorsS Kaleem Ahmed, Nicole N Haese, Jaden T Cowan, et al.Leukemia|February 19, 2021
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trialChristoph Röllig, Hubert Serve, Richard Noppeney, et al.American Journal of Hematology|October 2, 2025
Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA TrialKatja Sockel, Christoph Röllig, Anke Mütherig, et al.Pageof 202